Novel benzochromenes : design, synthesis, cytotoxicity, molecular docking and mechanistic investigations
Aim: A novel series of fused benzochromenes with expected cytotoxicity and HIF-1α inhibition was identified. Materials & methods: A bioisosterism-aided approach was applied to design new benzochromenes and assess their cytotoxicity against three cancer cell lines. The probable mechanistic effect and the in silico docking and pharmacokinetic profiles of the most effective derivatives were evaluated. Results: Compounds 3, 4, 5, 8 and 11 showed potent antiproliferative activity and excellent selectivity. Compound 8 showed significant HIF-1α inhibition with an IC50 value of 3.372 μM. It also enhanced apoptosis and arrested the HepG2 cell cycle at both the G0/G1 and S stages. Conclusion: Compound 8 was identified as a new potential anticancer candidate.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 16(2024), 2 vom: 16. Jan., Seite 105-123 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abdulrahman, Fatma G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 19.01.2024 Date Revised 19.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2023-0198 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367170167 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367170167 | ||
| 003 | DE-627 | ||
| 005 | 20240119232020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240116s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2023-0198 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1264.xml |
| 035 | |a (DE-627)NLM367170167 | ||
| 035 | |a (NLM)38226455 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abdulrahman, Fatma G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Novel benzochromenes |b design, synthesis, cytotoxicity, molecular docking and mechanistic investigations |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.01.2024 | ||
| 500 | |a Date Revised 19.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Aim: A novel series of fused benzochromenes with expected cytotoxicity and HIF-1α inhibition was identified. Materials & methods: A bioisosterism-aided approach was applied to design new benzochromenes and assess their cytotoxicity against three cancer cell lines. The probable mechanistic effect and the in silico docking and pharmacokinetic profiles of the most effective derivatives were evaluated. Results: Compounds 3, 4, 5, 8 and 11 showed potent antiproliferative activity and excellent selectivity. Compound 8 showed significant HIF-1α inhibition with an IC50 value of 3.372 μM. It also enhanced apoptosis and arrested the HepG2 cell cycle at both the G0/G1 and S stages. Conclusion: Compound 8 was identified as a new potential anticancer candidate | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a HIF | |
| 650 | 4 | |a HepG2 | |
| 650 | 4 | |a apoptosis | |
| 650 | 4 | |a benzochromene | |
| 650 | 4 | |a cell cycle | |
| 650 | 4 | |a chromenopyridine | |
| 650 | 4 | |a chromenopyrimidine | |
| 650 | 4 | |a cytotoxicity: cancer | |
| 650 | 4 | |a synthesis | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Abulkhair, Hamada S |e verfasserin |4 aut | |
| 700 | 1 | |a Zidan, Riham A |e verfasserin |4 aut | |
| 700 | 1 | |a Alwakeel, Asmaa I |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Karmalawy, Ahmed A |e verfasserin |4 aut | |
| 700 | 1 | |a Husseiny, Ebtehal M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 16(2024), 2 vom: 16. Jan., Seite 105-123 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:2 |g day:16 |g month:01 |g pages:105-123 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2023-0198 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 2 |b 16 |c 01 |h 105-123 | ||